Intravenous Injection of Autologous Bone Marrow Derived Mononuclear Cells in Ischemic Stroke Patients in Iraq

Abstract

Stroke is a leading cause of adult disability worldwide and the second highest cause of death in the world. Mortality rate is about 20% and another third are left with permanent disability. Treatments for stroke are based on methods that restore the flow of blood to the brain, such as clot-busting enzymes, surgery, and drugs for thinning blood, stopping clots and protecting neurons. Scientists believe that mesenchymal stem cell protection may be due to secretion of growth factors that promote growth of new neurons, regulate the immune system and stimulate the formation of new blood vessel, Or due to neurogenesis. Autologous bone marrow derived mononuclear cells with closed method is very near to minimal manipulation and low risk procedure. In this study, we aspirated 100 cc (mean volume) of bone marrow from 50 Iraqi adult patients (age ranges 34-86 years) (12 females 38 male) after filtration we injected 40 cc volume intravenously, mononuclear cell count was =5-6x10 7per product. The time from diagnosis till procedure performance was (3months-5 years), The effect of intravenous administration of autologous bone marrow mononuclear cells (BMMNCs) lead to improvement in European scale for stroke (+4-20) in 28 patients out of 50 (56%) in 4-8 weeks ). This study shows the positive effect of autologous bone marrow derived mononuclear cells in the functional recovery of adult patients with chronic ischemic stroke. Stroke is a leading cause of adult disability worldwide and the second highest cause of death in the world. Mortality rate is about 20% and another third are left with permanent disability. The majority of strokes (85%) are ischemic, while 15% is hemorrhagic due to a rupture of a brain artery causes bleeding into the brain tissue. Risk factors for stroke include high blood pressure, irregular heartbeat, diabetes, smoking, carotid artery narrowing, high blood cholesterol, increasing age, and lifestyle factors (exercise, diet and alcohol). Preventive measures include a diet low in fat and sodium, controlling blood pressure and alcohol intake, maintaining healthy weight, and regular exercise. Treatments for stroke are based on methods that restore the flow of blood to the brain, such as clotbusting enzymes, surgery, and drugs for thinning blood, stopping clots and protecting neurons [1,2]. Local Stem cells might be activated or transplanted from the same patient or another healthy one or from embryonic or cord blood sources [3]. There are many sources of stem cells used clinically to treat ischemic stroke including autologous bone marrow derived or adipose derived stem cells or cultured mesenchymal cells, neural cells derived from embryo, or cord blood cells induced pluripotent stem cells, and Wharton jelly mesenchymal cells. The trials underway are providing preliminary proof of the safety and potential effectiveness of the treatment, but there is still a long way to go before they show significant clinical changes for patients [4]. Safety issues, cell tracking and effectiveness are very vital issues in validating stem cell translational therapy [5].

Authors and Affiliations

Abdul Majeed Alwan Hammadi, Fizel Abbas Al-himyari

Keywords

Related Articles

Influence of Physical Activity on the Quality of of Breast Cancer Patients

Introduction: Breast cancer is the most common neoplasm among women. As a consequence of the increased number of cancer diagnoses, and concomitant mortality reductions for most types of cancer many patients live with phy...

Relationship between Chakra Energy and Consciousness

In the Hindu philosophy it is clearly mentioned that the chakra energy in human body is directly related to the human consciousness. The present work deals with the experimental study to validate this fact and prove that...

Finite Element Study: Locus of Axis of Rotation of T11-T12 and T12-L1 Segments under Flexion/Extension and Axial Rotation Configurations

In human, the thoracolumbar junction (TLJ) is a transitional region where the normal kyphotic thoracic region shifts to the normal lordotic lumbar region; the coronally oriented facet joints of the thoracic region transf...

Redefining Exercise Intensity during Competition Swimming

Anaerobic contribution can quickly decrease, even in shorter time line events (20-30 sec, 200m running, 50m swimming). Previous authors have demonstrated aerobic contributions between 29 and 40% for various levels of ath...

Advanced Abdominal Pregnancy with Retained Placenta and Methotrexate-Induced Severe Bone Marrow Suppression: A Case Report

placenta remains in situ after laparotomy this may result in fetal complications. We report a case of advanced abdominal pregnancy with live fetus salvaged by laparotomy with the whole placenta retained. The patient was...

Download PDF file
  • EP ID EP566663
  • DOI 10.26717/BJSTR.2017.01.000113
  • Views 182
  • Downloads 0

How To Cite

Abdul Majeed Alwan Hammadi, Fizel Abbas Al-himyari (2017). Intravenous Injection of Autologous Bone Marrow Derived Mononuclear Cells in Ischemic Stroke Patients in Iraq. Biomedical Journal of Scientific & Technical Research (BJSTR), 1(1), 46-48. https://europub.co.uk/articles/-A-566663